Biological basis of late life depression

scientific article published in August 2012

Biological basis of late life depression is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1003836243
P356DOI10.1007/S11920-012-0279-6
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s11920-012-0279-6
P932PMC publication ID3752388
P698PubMed publication ID22562412

P50authorYvette I ShelineQ79466707
P2093author name stringBrianne M Disabato
P2860cites workAnterior cingulate cortical volumes and treatment remission of geriatric depressionQ24642093
Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination SurveyQ28168583
Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysisQ28262333
Hippocampus shape analysis and late-life depressionQ33324413
Diffuse microstructural abnormalities of normal-appearing white matter in late life depression: a diffusion tensor imaging studyQ33431542
Psychomotor slowing and subcortical-type dysfunction in depressionQ33629519
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trialQ33726069
Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up studyQ33844090
Amygdalae morphometry in late-life depressionQ33857645
Gray matter changes in late life depression--a structural MRI analysisQ33857687
Cytokines and the brain: implications for clinical psychiatryQ33900651
Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factorsQ33988553
MRI signal hyperintensities and treatment remission of geriatric depressionQ34160970
Three-dimensional surface mapping of the caudate nucleus in late-life depressionQ34267093
The relationship of depression and stressors to immunological assays: a meta-analytic reviewQ34375707
How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axisQ34390776
Progression of white matter hyperintensities in elderly individuals over 3 yearsQ34602174
Microstructural white matter abnormalities and remission of geriatric depressionQ34732676
Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI StudyQ35028141
Amygdala volume in late-life depression: relationship with age of onsetQ35188783
Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging studyQ35401616
Inflammatory mediators in the elderlyQ35766426
Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes.Q35994979
Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depressionQ36143834
Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imagingQ36317321
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlationsQ36482713
Depression and cognition in older adultsQ37087209
Neurocognitive correlates of response to treatment in late-life depressionQ37293670
Depressive symptoms and brain volumes in older adults: a longitudinal magnetic resonance imaging study.Q37320815
Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors.Q51943280
Longitudinal association of initiation/perseveration and severity of geriatric depression.Q51944004
Subcortical white matter lesions and functional impairment in geriatric depression.Q51960277
Persistence of neuropsychologic deficits in the remitted state of late-life depression.Q51982843
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.Q51995510
Prognostic value of frontal functional neuroimaging in late-onset severe major depression.Q53627016
Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depressionQ57244759
Inflammatory Proteins and Depression in the ElderlyQ57338024
Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia∗∗The opinions and assertions expressed herein are those of the authors and are not to be construed as reflectQ57392445
Soluble cell adhesion molecules in late-life depressionQ57813708
Increase in Interleukin-1β in Late-Life DepressionQ57813826
Hippocampal volume change in depression: Late- and early-onset illness comparedQ57813860
Elevation in Late-Life Depression of Intercellular Adhesion Molecule-1 Expression in the Dorsolateral Prefrontal CortexQ57814052
The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepressionQ58479272
Hippocampal volume in geriatric depressionQ74227453
Inflammatory markers in late-life depression: results from a population-based studyQ80837482
MRI High-Intensity Signals in Late-Life Depression and Alzheimer's Disease: A Comparison of Subjects Without Major Vascular Risk FactorsQ38771335
Association of interleukin-6 and other biologic variables with depression in older people living in the communityQ39484897
Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS studyQ39956247
Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speedQ40357986
C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998.Q40393807
Greater MRI lesion volumes in elderly depressed subjects than in control subjectsQ40417825
White Matter Hyperintensity Progression and Late-Life Depression OutcomesQ40550525
Cytokines and the hepatic acute phase responseQ41474260
'Vascular depression' hypothesisQ41616775
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetineQ42167218
Dual-task performance in depressed geriatric patients.Q43641332
The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatientsQ43854243
Neuropsychological functioning and MRI signal hyperintensities in geriatric depressionQ43966382
Frontal white matter microstructure and treatment response of late-life depression: a preliminary studyQ44201503
Memory impairment in patients with late-onset major depression: the effect of antidepressant therapyQ44239552
Cognitive functioning and the natural course of depressive symptoms in late lifeQ44490877
Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study).Q44616016
Prefrontal brain morphology and executive function in healthy and depressed elderlyQ44671560
Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA studyQ44811011
Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression.Q44833286
Changes in cognitive functioning following treatment of late-life depressionQ44944122
Neuroanatomical and neuropsychological features of elderly euthymic depressed patients with early- and late-onsetQ45033558
A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.Q45130108
Executive dysfunction and the course of geriatric depressionQ46600037
Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition studyQ47657388
Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortexQ48102665
Prefrontal dysfunction and treatment response in geriatric depressionQ48144033
MRI Lesion Severity and Mortality in Geriatric DepressionQ48148807
Subcortical lesion severity and orbitofrontal cortex volume in geriatric depressionQ48213622
Vascular health and longitudinal changes in brain and cognition in middle-aged and older adultsQ48220739
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depressionQ48243726
Event-related potentials in an emotional go/no-go task and remission of geriatric depressionQ48266673
Six-month outcomes for MRI-related vascular depression.Q48317641
Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study.Q48363247
Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression.Q48364631
White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study.Q48413153
Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.Q48443459
White matter hyperintensity signals in psychiatric and nonpsychiatric subjectsQ48486109
Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration.Q48523953
Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly.Q48526290
Hippocampal volume and antidepressant response in geriatric depression.Q48552840
Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain.Q48642151
MRI-defined vascular depression.Q48753769
MRI signal hyperintensities and failure to remit following antidepressant treatment.Q48820688
Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort.Q48923423
MRI signal hyperintensities in geriatric depression.Q48937476
Cognitive impairment in late-onset depression. Limited to a decrement in information processing resources?Q49081612
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.Q49143781
Signal hyperintensities on brain magnetic resonance imaging in elderly depressed patients.Q51000645
The pattern and course of cognitive impairment in late-life depression.Q51865017
Response inhibition predicts poor antidepressant treatment response in very old depressed patients.Q51902253
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectlate life depressionQ438896
P304page(s)273-279
P577publication date2012-08-01
P1433published inCurrent Psychiatry ReportsQ25245507
P1476titleBiological basis of late life depression
P478volume14

Reverse relations

cites work (P2860)
Q48073679Altered serum fatty acid composition in geriatric depression
Q97437006Association of Markers of Microvascular Dysfunction With Prevalent and Incident Depressive Symptoms: The Maastricht Study
Q30724976Brain network dysfunction in late-life depression: a literature review
Q50531989Depressive Symptom Dimensions and Their Association with Hippocampal and Entorhinal Cortex Volumes in Community Dwelling Older Adults.
Q37699075Depressive symptoms, symptom dimensions, and white matter lesion volume in older adults: a longitudinal study
Q36915385Dimensions of depressive symptoms and cingulate volumes in older adults
Q38067355Duloxetine: a review of its use in the management of major depressive disorder in older adults
Q30920004Increased cerebral water content in hemodialysis patients
Q47287511Late-Life Depressive Symptoms as Partial Mediators in the Associations between Subclinical Cardiovascular Disease with Onset of Mild Cognitive Impairment and Dementia
Q36383001Machine learning approaches for integrating clinical and imaging features in late-life depression classification and response prediction
Q35157110Multimodal brain connectivity analysis in unmedicated late-life depression.
Q44747074Organic bases of late-life depression: a critical update
Q28079484Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review
Q38103882Pharmacogenetic considerations for late life depression therapy
Q37308873Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study.
Q42374732Vascular depression consensus report - a critical update.
Q48002709Vertex-wise examination of depressive symptom dimensions and brain volumes in older adults

Search more.